On September 11, 2024, Celluris was present at the presentation of the finalists for the Inovo Award – Health Innovation, during the III Brazilian Health Innovation Summit, held at the WTC São Paulo. Although the company did not receive an award, its participation highlighted the impact of its innovative solutions in the field of health and biotechnology, particularly in the development of CAR-T immunotherapy for the treatment of oncology patients.
Inovation recognition
Patrícia Rozenchan, Executive Director of Research and Development at Celluris, commented on the importance of being among the finalists: “Participating in an award like Inovo is already a great recognition in itself. Being alongside such innovative companies and presenting our work to a qualified audience reinforces the value of what we are building at Celluris. We will remain focused on our mission to transform patients’ lives through innovation in oncology treatments.”
About Inovo Award
The Inovo Award – Health Innovation, promoted by Biominas Brasil, Sindusfarma, and the Brazilian Pharmaceutical Innovation Network (RBIF), recognizes startups that are revolutionizing the health sector in Brazil. Despite not holding the trophy, Celluris reaffirmed its commitment to leading scientific and technological advancements in oncology. Look at the photos:
